# Multimodal Pain Management Following Primary TKA

> **NCT02369523** · EARLY_PHASE1 · TERMINATED · sponsor: **University of Utah** · enrollment: 84 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Exparel
- **DRUG:** Ropivacaine cocktail (PIC)
- **DRUG:** Bupivacaine

## Key facts

- **NCT ID:** NCT02369523
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-09
- **Primary completion:** 2017-04
- **Final completion:** 2017-04
- **Target enrollment:** 84 (ACTUAL)
- **Why stopped:** Adequate enrollment was not reached for this study.
- **Last updated:** 2023-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02369523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02369523, "Multimodal Pain Management Following Primary TKA". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02369523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*